These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15241738)

  • 21. Cardiovascular complications of chronic renal failure - an updated review.
    Roy GC; Sutradhar SR; Barua UK; Datta NC; Debnath CR; Hoque MM; Hossain AS; Haider MS; Das M
    Mymensingh Med J; 2012 Jul; 21(3):573-9. PubMed ID: 22828566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of underlying cardiovascular disease among patients with end-stage renal disease.
    Hedayati SS; Szczech LA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):246-53. PubMed ID: 15241739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
    Raggi P; Boulay A; Chasan-Taber S; Amin N; Dillon M; Burke SK; Chertow GM
    J Am Coll Cardiol; 2002 Feb; 39(4):695-701. PubMed ID: 11849871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective.
    McCullough PA
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):591-600. PubMed ID: 15483448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for improving long-term survival in patients with ESRD.
    Nolan CR
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S120-7. PubMed ID: 16251247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular calcification in end-stage renal disease.
    Salusky IB; Goodman WG
    Nephrol Dial Transplant; 2002 Feb; 17(2):336-9. PubMed ID: 11812902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease in dialysis patients.
    Cozzolino M; Mangano M; Stucchi A; Ciceri P; Conte F; Galassi A
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii28-iii34. PubMed ID: 30281132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients.
    Ikizler TA
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):162-71. PubMed ID: 15216487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension complicated with chronic kidney disease].
    Koizumi K; Ito S
    Nihon Rinsho; 2011 Nov; 69(11):2015-9. PubMed ID: 22111323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Undertreatment of cardiac risk factors in adolescents with renal failure.
    Querfeld U
    Perit Dial Int; 2001; 21 Suppl 3():S285-9. PubMed ID: 11887837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
    Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
    BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk assessment before and after kidney transplantation.
    Glicklich D; Vohra P
    Cardiol Rev; 2014; 22(4):153-62. PubMed ID: 24896248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis.
    Elghoroury EA; Fadel FI; Elshamaa MF; Kandil D; Salah DM; El-Sonbaty MM; Farouk H; Raafat M; Nasr S
    Pediatr Nephrol; 2018 Jun; 33(6):1019-1027. PubMed ID: 29313136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes.
    Dai L; Golembiewska E; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2017; 191():32-43. PubMed ID: 28910789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.
    Bejan-Angoulvant T; Bergerot C; Juillard L; Mezergues A; Morelon E; Pouteil-Noble C; André-Fouët X; Angoulvant D
    Nephrol Dial Transplant; 2012 Jul; 27(7):2886-91. PubMed ID: 22344775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.
    Yu TM; Lin CL; Shu KH; Liu YL; Chen CH; Huang ST; Kao CH
    Osteoporos Int; 2015 Feb; 26(2):785-93. PubMed ID: 25491767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.